AMAT vs EDIT · P/E 56, rev $28.37B vs rev $32.3M
Applied Materials Inc (AMAT) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported AMAT revenue for 2025-10-26 was $28.37B. Net income was $7.00B. Revenue was up 4.4% from 2024-10-27 to 2025-10-26. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the AMAT and EDIT stock pages for the full models.
Not investment advice.